BERETTA, SIMONE
 Distribuzione geografica
Continente #
NA - Nord America 13.106
AS - Asia 10.610
EU - Europa 5.737
SA - Sud America 1.400
AF - Africa 218
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 9
Totale 31.095
Nazione #
US - Stati Uniti d'America 12.363
SG - Singapore 3.749
VN - Vietnam 2.417
CN - Cina 1.843
IT - Italia 1.184
HK - Hong Kong 1.175
BR - Brasile 1.071
RU - Federazione Russa 1.037
DE - Germania 800
SE - Svezia 660
CA - Canada 601
IE - Irlanda 413
GB - Regno Unito 367
UA - Ucraina 291
FR - Francia 273
IN - India 260
BD - Bangladesh 208
FI - Finlandia 176
KR - Corea 152
TR - Turchia 129
AR - Argentina 128
ID - Indonesia 108
ES - Italia 93
IQ - Iraq 92
NL - Olanda 90
MX - Messico 86
AT - Austria 85
JP - Giappone 74
ZA - Sudafrica 67
PL - Polonia 56
PK - Pakistan 49
CO - Colombia 48
VE - Venezuela 45
PH - Filippine 44
SA - Arabia Saudita 43
UZ - Uzbekistan 42
EC - Ecuador 41
BE - Belgio 37
DK - Danimarca 31
EG - Egitto 31
LT - Lituania 28
CH - Svizzera 23
MA - Marocco 23
CZ - Repubblica Ceca 22
MY - Malesia 22
KE - Kenya 21
CL - Cile 20
TH - Thailandia 20
IR - Iran 19
JO - Giordania 16
PY - Paraguay 16
AE - Emirati Arabi Uniti 15
TN - Tunisia 14
NP - Nepal 13
PE - Perù 13
AZ - Azerbaigian 12
ET - Etiopia 12
OM - Oman 12
UY - Uruguay 12
DZ - Algeria 11
IL - Israele 11
JM - Giamaica 11
KG - Kirghizistan 11
LB - Libano 11
CR - Costa Rica 10
DO - Repubblica Dominicana 10
SN - Senegal 10
GR - Grecia 8
HU - Ungheria 8
MN - Mongolia 8
AL - Albania 7
BG - Bulgaria 7
AU - Australia 6
EU - Europa 6
GE - Georgia 6
KZ - Kazakistan 6
PS - Palestinian Territory 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AO - Angola 5
BO - Bolivia 5
PA - Panama 5
RO - Romania 5
SY - Repubblica araba siriana 5
TW - Taiwan 5
CI - Costa d'Avorio 4
HR - Croazia 4
KH - Cambogia 4
LV - Lettonia 4
MD - Moldavia 4
TG - Togo 4
AM - Armenia 3
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
BY - Bielorussia 3
EE - Estonia 3
HN - Honduras 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
MM - Myanmar 3
NI - Nicaragua 3
Totale 31.034
Città #
Singapore 1.841
Ann Arbor 1.382
Ashburn 1.333
Hong Kong 1.135
San Jose 960
Hanoi 689
Ho Chi Minh City 676
Chandler 644
Woodbridge 635
Fairfield 517
Houston 508
Frankfurt am Main 455
Toronto 435
Dublin 402
Los Angeles 359
New York 351
Santa Clara 351
Dallas 346
Jacksonville 303
Wilmington 280
Hefei 271
Milan 269
Seattle 246
Beijing 245
The Dalles 218
Chicago 215
Dearborn 214
Cambridge 199
Princeton 173
Seoul 143
Boardman 136
Buffalo 124
Hangzhou 123
Lauterbourg 122
Shanghai 115
São Paulo 109
Council Bluffs 107
Da Nang 101
Moscow 85
Nanjing 78
Helsinki 76
Altamura 74
Jakarta 73
Orem 73
Munich 70
Lawrence 68
Haiphong 65
Nuremberg 62
Tokyo 61
Montreal 56
Guangzhou 52
Dong Ket 51
Lachine 51
London 51
Denver 49
San Diego 47
Vienna 45
Hải Dương 44
Warsaw 44
Biên Hòa 43
Baghdad 41
Rome 40
Quận Bình Thạnh 37
Tashkent 36
Brussels 35
Can Tho 35
Rio de Janeiro 35
Shenyang 35
Atlanta 34
Brooklyn 34
Mountain View 34
Poplar 34
Thái Nguyên 34
Quận Một 33
Manchester 31
Johannesburg 30
Nanchang 30
Dhaka 29
Fremont 29
Phoenix 29
San Francisco 29
Stockholm 29
Hebei 27
Mexico City 27
Vũng Tàu 27
Andover 26
Turku 26
Amsterdam 25
Ninh Bình 25
Istanbul 24
Boston 23
Bắc Giang 23
Ha Long 22
Salt Lake City 22
Zhengzhou 22
Ankara 21
Changsha 21
Chennai 21
Madrid 21
Columbus 20
Totale 19.206
Nome #
Harmonization of sensorimotor deficit assessment in a registered multicentre pre-clinical randomized controlled trial using two models of ischemic stroke 1.098
Exploring Sex Differences in Outcomes of Dual Antiplatelet Therapy for Patients With Noncardioembolic Mild-to-Moderate Ischemic Stroke or High-Risk Transient Ischemic Attack: A Propensity-Matched Analysis of the READAPT Study Cohort 561
Head down tilt 15° in experimental intracerebral hemorrhage: a randomized non-inferiority safety trial 541
Head Down Tilt 15° in Acute Ischemic Stroke with Poor Collaterals: A Randomized Preclinical Trial 475
The role of clinical and neuroimaging features in the diagnosis of CADASIL 434
Prognostic Value of Signal Abnormalities on Brain MRI in Post-Anoxic Super-Refractory Status Epilepticus: A Single-Center Retrospective Study 424
Selective Cerebrospinal Fluid Hypothermia: Bioengineering Development and In Vivo Study of an Intraventricular Cooling Device (V-COOL) 396
Multicentre translational Trial of Remote Ischaemic Conditioning in Acute Ischaemic Stroke (TRICS): protocol of multicentre, parallel group, randomised, preclinical trial in female and male rat and mouse from the Italian Stroke Organization (ISO) Basic Science network 390
Guillain-Barré syndrome related to COVID-19 infection 388
Clinical pregenetic screening for stroke monogenic diseases: Results from lombardia GENS registry 386
Neurologic outcome of postanoxic refractory status epilepticus after aggressive treatment 378
Implementation of continuous qEEG in two neurointensive care units by intensivists: a feasibility study 375
Cerebral collateral flow defines topography and evolution of molecular penumbra in experimental ischemic stroke 367
Incidence and predictors of acute symptomatic seizures after stroke 360
Multi-site laser Doppler flowmetry for assessing collateral flow in experimental ischemic stroke: Validation of outcome prediction with acute MRI 357
Case Report: Concomitant Massive Cerebral Venous Thrombosis and Internal Iliac Vein Thrombosis Related to Paucisymptomatic COVID-19 Infection 353
Cerebral collateral flow defines topography and evolution of molecular penumbra in experimental ischemic stroke 351
Riluzole Selective Antioxidant Effects in Cell Models Expressing Amyotrophic Lateral Sclerosis Endophenotypes 351
Two-year cardio-pulmonary follow-up after severe COVID-19: a prospective study 348
Intracranial collateral flow defines the boundaries of molecular penumbra in experimental ischemic stroke 341
Long-term applicability of the new ILAE definition of epilepsy. Results from the PRO-LONG study 331
Cerebral collateral therapeutics in acute ischemic stroke: A randomized preclinical trial of four modulation strategies 321
Oxidative stress impairs glutamate uptake in fibroblasts from patients with Alzheimer's disease 316
Topographical and morphological patterns of post reperfusion molecular penumbra 312
Intracranial Collateral flow defines the boundaries of molecular penumbra in experimental ischemic stroke 310
Riluzole display glutamate-independent antioxidant properties: relevance for ALS 308
Systemic thrombolysis in patients with acute ischemic stroke and internal carotid artery occlusion: The ICARO study 307
Prognostic patterns and predictors in epilepsy: A multicentre study (PRO-LONG) 302
Neurological outcome of postanoxic refractory status epilepticus after aggressive treatment 301
Leber hereditary optic neuropathy mtDNA mutations disrupt glutamate transport in cybrid cell lines 296
Therapeutic modulation of intracranial collateral flow improves outcome in experimental ischemic stroke 294
Impact of COVID-19 on functional, cognitive, neuropsychiatric, and health-related outcomes in patients with dementia: A systematic review 291
SARS-CoV-2 infection and acute ischemic stroke in Lombardy, Italy 289
Guillain–Barré Syndrome Associated with COVID-19 288
Comorbidities in patients with epilepsy: Frequency, mechanisms and effects on long-term outcome 288
Pravastatin acute neuroprotective effects depend on blood brain barrier integrity in experimental cerebral ischemia 286
Common variation in PHACTR1 is associated with susceptibility to cervical artery dissection 286
Impairment of glutamate transport and increased vulnerability to oxidative stress in neuroblastoma SH-SY5Y cells expressing a Cu,Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis 282
Hemodynamic monitoring of intracranial collateral flow predicts tissue and functional outcome in experimental ischemic stroke 281
Absence and reappearance of N20 response after thiopental withdrawal in postanoxic coma 275
Multi-pathway blood biomarkers to target and monitor multidimensional prevention of cognitive and functional decline (nested in the IN-TeMPO study framed within the world-wide FINGERS network) 273
Intracranial collateral flow in experimental ischemic stroke. From hemodynamic monitoring to collateral therapeutics 270
Hemodynamic monitoring of intracranial collateral flow predicts tissue and functional outcome in experimental ischemic stroke 270
Clinical factors associated with statins prescription in acute ischemic stroke patients: Findings from the Lombardia Stroke Registry 269
A multidisciplinary approach to screen the post-COVID-19 conditions 266
Combining Intravenous Thrombolysis and Dual Antiplatelet Treatment in Patients With Minor Ischemic Stroke: A Propensity Matched Analysis of the READAPT Study Cohort 266
Mitochondrial dysfunction due to mutant copper/zinc superoxide dismutase associated with amyotrophic lateral sclerosis is reversed by N-acetylcysteine 266
Thermal plantar test in experimental ischemic stroke 264
Long-term risk of chronic epilepsy in adults after post-anoxic coma and refractory status epilepticus: A retrospective cohort study 263
COVID‐19‐associated immune‐mediated encephalitis mimicking acute‐onset Creutzfeldt‐Jakob disease 261
Experimental in-vivo model of intravascular shunting for neurosurgical bypass 260
Acute lipophilicity-dependent effect of intravascular simvastatin in the early phase of focal cerebral ischemia 256
Cerebral collateral therapeutics in experimental ischemic stroke: a randomized preclinical trial of four modulation strategies 254
The management of epilepsy in clinical practice: Do the needs manifested by the patients correspond to the priorities of the caring physicians? Findings from the EPINEEDS Study 254
Lack of evidence for oxidative stress in sporadic amyotrophic lateral sclerosis fibroblasts 253
Oxidative stress in peripheral blood mononuclear cells from patients with Parkinson's disease: negative correlation with levodopa dosage 252
Headache in cerebral venous thrombosis associated with extracranial tumors: a clinical series 249
Intravenous thrombolysis for acute ischemic stroke associated to extracranial internal carotid artery occlusion: The ICARO-2 study 244
Cerebral collateral circulation in experimental ischemic stroke 242
The THRombolysis and STatins (THRaST) study 241
Chapter 16. Impact of COVID-19 on pre-existing neurological diseases 237
Effectiveness and safety of adjunctive cenobamate in people with focal-onset epilepsy: Interim results after 24-week observational period from the BLESS study 236
Optimized system for cerebral perfusion monitoring in the rat stroke model of intraluminal middle cerebral artery occlusion 235
Head down tilt 15° to preserve salvageable brain tissue in acute ischemic stroke: A pre-clinical pooled analysis, with focus on cerebral hemodynamics 229
Impact of SARS-CoV-2 on reperfusion therapies for acute ischemic stroke in Lombardy, Italy: the STROKOVID network 228
Enhanced recovery strategies in colorectal surgery: is the compliance with the whole program required to achieve the target? 227
Partial mitochondrial complex I inhibition induces oxidative damage and perturbs glutamate transport in primary retinal cultures. Relevance to Leber Hereditary Optic Neuropathy (LHON) 216
From observation to monitoring: implementation of quantitative electroencephalography (QEEG) in neurointensive care 216
Oxidative stress in peripheral blood mononuclear cells from patients with Parkinson's disease: negative correlation with levodopa dosage 215
Double antiglutamatergic therapy in a case of postanoxic super-refractory status epilepticus 215
Guillain-Barré syndrome AMSAN variant in a 90-year-old woman after COVID-19: a case report 214
Efficacy and safety of perampanel oral loading in postanoxic super-refractory status epilepticus: A pilot study 209
Discontinuation of antiseizure medications in seizure-free patients with long-term follow-up: Patients’ profile, seizure recurrence, and risk factors 208
Intravenous thrombolysis or endovascular therapy for acute ischemic stroke associated with cervical internal carotid artery occlusion: the ICARO-3 study 205
Efficacy and tolerability of low versus standard daily doses of antiseizure medications in newly diagnosed focal epilepsy. A multicenter, randomized, single-blind, non-inferiority trial (STANDLOW) 202
Comprehensive educational plan for patients with epilepsy and comorbidity (EDU-COM): A pragmatic randomised trial 201
Multi-Center Randomized Phase II Clinical Trial on Remote Ischemic Conditioning in Acute Ischemic Stroke Within 9 Hours of Onset in Patients Ineligible to Recanalization Therapies (TRICS-9): Study Design and Protocol 201
Neutrophils predominate the immune signature of cerebral thrombi in COVID-19 stroke patients 199
Pharmacological manipulation of glutamate transport 196
Peripheral markers of glutamatergic dysfunction in neurological disease: focus on ex vivo tools 194
Multicentre case-control study on the association between COVID-19 vaccines and neurological disorders (COVIVAX) 192
A real-world comparison among third-generation antiseizure medications: Results from the COMPARE study 189
Brain ultrasound rehearsal before surgery: A pilot cadaver study 189
Interactions between excitotoxicity and oxidative stress in ALS: clues for pharmacotherapy 188
Association of vascular risk factors with cervical artery dissection and ischemic stroke in young adults 184
The management of epilepsy in clinical practice: Do the timing and severity of the disease influence the priorities of patients and the caring physicians? Data from the EPINEEDS study 182
Perampanel in post-stroke epilepsy: Clinical practice data from the PERampanel as Only Concomitant antiseizure medication (PEROC) study 181
Antioxidants partially restore glutamate transport defect in leber hereditary optic neuropathy cybrids 181
Spectral properties of the EEG during recovery of consciousness after acute brain injury 180
Divergence Between Clinical Trial Evidence and Actual Practice in Use of Dual Antiplatelet Therapy After Transient Ischemic Attack and Minor Stroke 177
Pathogenesis of retinal ganglion cell death in Leber hereditary optic neuropathy (LHON): possible involvement of mitochondria, light and glutamate 177
Elevated peripheral leukocyte counts in acute cervical artery dissection 176
Possible neuroprotective strategies in ALS 174
Quantitative EEG interpretation by EEG-naïve neurointensivists before and after expert training 173
Head down positioning before recanalization in acute ischemic stroke 173
COVID-19-associated Guillain-Barré syndrome in the early pandemic experience in Lombardia (Italy) 170
Thrombolysis in Cervical Artery Dissection - Data from the Cervical Artery Dissection and Ischaemic Stroke Patients (CADISP) database 167
Early ficolin-1 is a sensitive prognostic marker for functional outcome in ischemic stroke 167
Incidence and Long-term Functional Outcome of Neurologic Disorders in Hospitalized Patients with COVID-19 Infected with Pre-Omicron Variants 164
Real-World Dual Antiplatelet Therapy Use Exceeds Randomized Trials Boundaries With Possible Safety Issues in Patients With Large Artery Atherosclerosis—Insights From the READAPT Study 158
Totale 27.636
Categoria #
all - tutte 96.561
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 96.561


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021159 0 0 0 0 0 0 0 0 0 0 0 159
2021/20221.378 129 137 155 87 106 98 52 54 77 111 146 226
2022/20232.259 257 710 202 224 118 328 24 138 132 10 64 52
2023/20241.818 46 38 95 115 198 393 362 52 176 18 63 262
2024/20256.822 266 487 239 203 440 266 348 201 533 840 846 2.153
2025/202613.416 1.750 956 1.047 1.392 1.639 684 1.995 583 971 1.241 876 282
Totale 31.793